Anti-Human Phosphodiesterase V (PDE-5)

Anti-Human Phosphodiesterase V (PDE-5)

Product No.: P164

[product_table name="All Top" skus="P164"]

- -
- -
Clone
29.29
Target
Phosphodiesterase V
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
PDE-5
Isotype
IgG1
Applications
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Mouse
Product Concentration
0.5 mg/ml
Formulation
This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Storage and Handling
This purified antibody is stable when stored at 2-8°C. Do not freeze.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Mouse Anti-Human Phosphodiesterase V (Phosphodiesterase V) (Clone 29.29) recognizes an epitope on Human Phosphodiesterase V. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background
Phosphodiesterases (PDEs) are a superfamily of enzymes that degrade the intracellular second messengers cyclic AMP and cyclic GMP. These enzymes are essential regulators of cyclic nucleotide signaling with diverse physiological functions. PDEs are drug targets for the treatment of disease states including heart failure, depression, asthma, inflammation and erectile dysfunction. Of the 12 PDE gene families, cGMP specific PDE5 carries out the principal cGMP hydrolyzing activity.1,2

Antigen Details

Research Area
Apoptosis
.
Cell Biology
.
Immunology

References & Citations

1. Piazza, G. et al. (2001) Cancer Research 61:3961-3968
2. Sung, BJ. et al. (2003) Nature 425:98-102
General Western Blot Protocol

Formats Available

- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.